Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (8 ops.)
Latest filing published 08 Oct 2026 for RESMED INC, €649k. Read the official filing
Filing timeline
BuySaleMichael J. Farrell
Insider track record
Disclosed buys
0
Disclosed sells
8
Signal history
Michael J. Farrell: trading record in brief
This profile gathers the share dealings of Michael J. Farrell in ResMed Inc, where the filings describe the role as chief executive. Between 15 January 2016 and 7 October 2026, the trades on record add up to 78 filings.
On the market, this insider has only sold: 8 sales, €4.8M in total. The totals do not cover 3 filings with an undisclosed amount. Besides market trades, the filings include 14 share grants and 53 option exercises. Since January 2026: no purchases and 6 sales on the market.
On 8 October 2026 came the latest disclosure, an open-market sale for €1.0M in ResMed Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Michael J. Farrell
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations78 total
4,991 shares@ US$146.34ResMed Common StockSEC:0000943819-26-000085:0
4,991 shares@ US$226.3349ResMed Common StockSEC:0000943819-26-000085:1
13,547 shares0ResMed Common StockSEC:0000943819-26-000075:0
4,991 shares@ US$146.340.0022% mcap1.2% of flowResMed Common StockSEC:0000943819-26-000052:0
4,991 shares@ US$222.43850.0033% mcap1.8% of flowResMed Common StockSEC:0000943819-26-000052:1
4,991 shares@ US$205.68950.0031% mcap1.7% of flowResMed Common StockSEC:0000943819-26-000043:1
4,991 shares@ US$146.340.0022% mcap1.2% of flowResMed Common StockSEC:0000943819-26-000043:0
4,991 shares@ US$146.340.0022% mcap1.2% of flowResMed Common StockSEC:0000943819-26-000038:0
4,991 shares@ US$218.54750.0033% mcap1.8% of flowResMed Common StockSEC:0000943819-26-000038:1
4,991 sharesResMed Common StockSEC:0000943819-26-000035:0
4,991 sharesResMed Common StockSEC:0000943819-26-000035:1
4,991 shares@ US$146.341.2% of flowResMed Common StockSEC:0000943819-26-000021:0
4,991 shares@ US$225.50321.8% of flowResMed Common StockSEC:0000943819-26-000021:1
4,991 shares@ US$146.341.2% of flowResMed Common StockSEC:0000943819-26-000016:0
4,991 shares@ US$146.341.2% of flowResMed Common StockSEC:0000943819-26-000011:0
4,991 shares@ US$146.341.2% of flowResMed Common StockSEC:0000943819-26-000003:0
4,991 shares@ US$146.341.2% of flowResMed Common StockSEC:0000943819-25-000187:0
13,551 shares0ResMed Common StockSEC:0000943819-25-000170:0
2,231.545 shares@ US$250.100.9% of flowResMed Common StockSEC:0000943819-25-000116:0
983 shares@ US$101.640.2% of flowResMed Common StockSEC:0000943819-25-000095:0
8,009 shares@ US$101.641.3% of flowResMed Common StockSEC:0000943819-25-000086:0
8,009 shares@ US$101.641.3% of flowResMed Common StockSEC:0000943819-25-000061:0
12,289 shares0ResMed Common StockSEC:0000943819-25-000039:0
8,009 shares@ US$101.641.3% of flowResMed Common StockSEC:0000943819-25-000038:0
8,009 shares@ US$101.641.3% of flowResMed Common StockSEC:0000943819-25-000027:0
25 of 78 declarations
